Ad
related to: fda drug approvals 2023
Search results
Results From The WOW.Com Content Network
In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...
Pozelimab was approved for medical use in the United States in August 2023. [ 3 ] [ 4 ] It is the first FDA-approved treatment for CHAPLE disease. [ 3 ] [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .
It was granted accelerated approval for medical use in the United States in January 2023, [27] and fully approved by the FDA in July 2023. [ 24 ] [ 28 ] Lecanemab was approved for medical use in South Korea in May 2024, [ 29 ] and in Mexico in December 2024.
One such medication is mirikizumab — sold under the brand name Omvoh — which received Food and Drug Administration (FDA) approval for the treatment of ulcerative colitis in October 2023.
Nirogacestat was approved for medical use in the United States in November 2023. [2] It is the first medication approved by the US Food and Drug Administration (FDA) for the treatment of desmoid tumors. [2] [5] The FDA considers it to be a first-in-class medication. [6]